Bayer AG
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
501 / 1328
Position in country
404 / 963
Return on Assets, %
-2.5
-2.7
Net income margin, %
11.3
2.8
EBITDA margin, %
25.7
10.8
Debt to Equity, %
136.6
19.2
Intangible assets and goodwill, %
47.8
3.6
Revenue CAGR 3Y, %
4.7
8.5
Total Equity change 1Y, %
-12.5
0
Revenue Y, % chg
-3.5
0.5
P/BV
0.8
1.5
P/S
0.5
2.3
EV/S
1.2
2.4
EV/EBITDA
3.2
7.4
Average Analyst recommendation
Hold
Hold
Average upside forecasts, %
302.3
51.3
Forward P/E
2.4
15.6
Dividend Yield, %
0.4
1.7
Forward Dividend Yield, %
25.5
0.2
Expected dividend per share
1.8
0
Dividend Ex Date
2024-04-29
Competitors
Ranks
-
Novo Nordisk A/S
00%
-
AstraZeneca PLC
00%
-
Bayer AG
00%
-
Eli Lilly and Co
00%
-
Roche Holding AG
00%
-
Merck KGaA
00%
-
Dermapharm Holding SE
00%
-
Novartis AG
00%
-
Johnson & Johnson
00%
-
Merck & Co Inc
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
Germany
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Pharmaceuticals
Sub-sector
Health Care
Capitalization (millions of $)
28408.9
Ticker
BAYRY.PK
ISIN
US0727303028
IPO date
1997-11-28
Availability on Russian exchanges
Yes
Reporting for
2024-03-05
Date fact. publication of reports
2023-12-31
Company Description
Bayer AG is a German-based life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The company is focusing on their oncology platform o Targeted Alpha Therapies for treating prostate cancer. Th Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment researches, develops and markets crop protection solutions and seeds, and includes the subsidiary Monsanto. The Animal Health segment is engaged in the development, production and marketing of prescription and non
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: